Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy
Rong Xiao, Ye Tian, Jiwei Zhang, Na Li, Mei Qi, Ling Liu, Jianping Wang, Zhenyu Li, Jie Zhang, Fabao Zhao, Tixiao Wang, Siyu Tan, Chunyang Li, Zhuanchang Wu, Mingyan Yu, Xuemei Jiang, Peng Zhan, Lifen Gao, Bo Han, Xinyong Liu, Xiaohong Liang, Chunhong Ma
Topics & Concepts
SIGLECImmunotherapyMedicineCancer researchImmunologyImmune systemImmune Cell Function and InteractionGlycosylation and Glycoproteins ResearchImmune cells in cancer